ArticleMolecular therapy oncolytics2022

Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response.

Yalei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.